The global angiogenesis assays market is experiencing unprecedented growth, as highlighted in a recent report by Future Market Insights. Valued at USD 1,972.1 million in 2022, the industry is expected to reach USD 2,139.7 million by the end of 2023, marking a promising CAGR of 9.10% over the forecast period from 2023 to 2033. By 2033, the market is projected to surge further to a staggering USD 5,112.2 million, reflecting the rising importance of angiogenesis assays in the medical and pharmaceutical sectors.
Driving Forces Behind the Growth:
The demand for angiogenesis assays is fueled by their critical role in studying the formation of new blood vessels, a process crucial for understanding and addressing diseases such as cancer, cardiovascular disorders, and ophthalmic conditions. These assays have become essential in drug development, personalized medicine, and disease diagnostics, paving the way for innovative healthcare solutions.
Advancements in medical research and the need for precision tools have spurred investments in research and development (R&D) and strategic collaborations, creating a fertile ground for the angiogenesis assays market to thrive.
Key Insights from the Report
- The angiogenesis assays market demonstrated a CAGR of 7.3% between 2017 and 2022.
- North America dominates the market, holding a 38.1% share, with the United States alone accounting for 43.0%.
- Asia-Pacific, driven by countries like India (CAGR of 10.9%) and China (CAGR of 10.2%), is emerging as a significant growth region.
- Europe follows North America, with the United Kingdom and Germany playing key roles in the region’s 29.3% market share.
- Among applications, in vitro angiogenesis accounts for 63.0% of the market share, while hospitals remain the largest end-user segment at 48.0%.
Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!
Competitive Landscape:
Prominent players in the market include:
- Cell Biolabs, Inc.
- Thermo Fisher Scientific
- Abcam plc.
- PromoCell GmbH
- Merck KGaA
- ATCC
- Corning Incorporated
These companies are driving innovation through new product launches, partnerships, and R&D investments. For example, in February 2023, Merck announced its agreement to sell a significant campus to Onyx Equities, reflecting strategic shifts to enhance core operations.
Future Prospects and Opportunities:
The global angiogenesis assays market is positioned for robust growth, with increasing research activities and technological advancements unlocking new avenues for market players. Emerging trends in microfluidics, endothelial adhesion assays, and invasion and migration assays are anticipated to reshape the landscape, offering new opportunities for innovation and market expansion.
“The rise in R&D activities and the growing focus on precision medicine are major drivers propelling the angiogenesis assays market forward,” commented a Future Market Insights analyst.
Key Segments Profiled in the Angiogenesis Assay Industry Survey:
Product Type:
- Angiogenesis Tube Formation Assays
- Microfluidic
- Endothelial Adhesion
- Invasion and Migration Assays
Application:
- In Vitro Angiogenesis
- In Vivo Angiogenesis
End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific excluding Japan
- China
- Japan
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube